Researchers have found that ASPM acts as a novel regulator in promoting stemness by augmenting Wnt-Dvl-3-β-catenin signaling, and activation of Wnt signaling in cancer stem cells contributes to cancer progression in malignant tumors (Pai et al., 2019). This evidence concerns the gene DVL3 and cancer.